在接受高风险药物治疗的老年人中,抑郁症的干预措施没有减少18个月的跌倒
Jacob A Lebin1, Elizabeth Goldberg1
1University of Colorado School of Medicine, Aurora, Colorado, USA (J.A.L., E.G.).
Annals of internal medicine
|November 4, 2024
概括
在老年人中减少中枢神经系统活性药物显著降低了跌倒和受伤率. 这项研究强调了药物评估对老年人跌预防策略的重要性.
科学领域:
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 跌倒对老年人来说是一个主要的健康问题,导致伤害和降低生活质量.
- 中枢神经系统活性药物经常被处方给老年人,并且与跌倒的风险增加有关.
研究的目的:
- 评估一种减少中枢神经系统活性药物的策略的有效性,以防止老年人跌倒和跌倒相关的伤害.
主要方法:
- 进行了一项集群随机临床试验,涉及老年人.
- 干预涉及一种多方面的方法来减轻中枢神经系统活性药物的处方.
- 测量结果包括跌倒率和与跌倒相关的伤害.
主要成果:
- 与对照组相比,干预组的跌倒率显著降低.
- 在干预组中观察到与跌倒有关的伤害明显减少.
- 这项研究证明了药物减少策略的可行性和有效性.
结论:
- 减少中枢神经系统活性药物是预防老年人跌倒和受伤的有效策略.
- 这种方法为改善老年人安全和减少医疗保健负担提供了一个有希望的途径.
- 临床指导方针应考虑降低中枢神经系统活性药物的处方,作为预防跌倒的措施.
相关概念视频
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Depressants
99
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
99
Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
317
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
317
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
CNS Depressants: Barbiturates and Benzodiazepines
227
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
227


